Do Platelet Function Assays Predict Clinical Outcomes in Clopidogrel Pretreated Patients Undergoing Elective PCI?

被引:0
|
作者
Hoffmann, S.
机构
关键词
D O I
10.1007/s00059-010-3324-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:50 / 50
页数:1
相关论文
共 50 条
  • [1] Effects of Prasugrel Versus Clopidogrel on Coronary Microvascular Function in Patients Undergoing Elective PCI
    Mangiacapra, Fabio
    Di Gioia, Giuseppe
    Pellicano, Mariano
    Di Serafino, Luigi
    Bressi, Edoardo
    Peace, Aaron J.
    Bartunek, Jozef
    Wijns, William
    De Bruyne, Bernard
    Barbato, Emanuele
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (02) : 235 - 237
  • [2] Platelet function assays in clopidogrel-treated patients undergoing cardiovascular surgery
    Bracey, A.
    Grigore, A.
    Allison, P. A.
    Feldman, D. F.
    Radovancevic, R.
    [J]. TRANSFUSION, 2007, 47 (03) : 191A - 191A
  • [3] No benefit of Clopidogrel Pretreatment in stable patients undergoing elective PCI
    Bellemain-Appaix, Anne
    O'Connor, Stephen A.
    Silvain, Johanne
    Cucherat, Michel
    Collet, Jean-philippe
    Bernasconi, Francois
    Montalescot, Gilles
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B44 - B44
  • [4] Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary intervention
    Sibbing, Dirk
    Busch, Gabriele
    Braun, Siegmund
    Jawansky, Stefan
    Schoemig, Albert
    Kastrati, Adnan
    Ott, Ilka
    von Beckerath, Nicolas
    [J]. EUROPEAN HEART JOURNAL, 2008, 29 (12) : 1504 - 1509
  • [5] Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel and undergoing elective percutaneous coronary intervention
    Sibbing, D.
    Busch, G.
    Jawansky, S.
    Braun, S.
    Vogt, W.
    Schomig, A.
    Kastrati, A.
    Ott, I.
    Von Beckerath, N.
    [J]. EUROPEAN HEART JOURNAL, 2008, 29 : 837 - 837
  • [6] Comparison of different platelet function assays for evaluation of the antiplatelet effects of clopidogrel in patients undergoing coronary intervention
    Trenk, D
    Hochholzer, W
    Frundi, D
    Neumann, FJ
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R154 - R154
  • [7] Prognostic impact of various platelet function assays and definitions of non-responsiveness to clopidogrel 600 mg on early outcome after elective PCI
    Tren, Dietmar
    Hochholzer, Willibald
    Stratz, Christian
    Valina, Christian M.
    Bestehorn, Hans-Peter
    Buettner, Heinz Joachim
    Neumann, Franz-Josef
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A226 - A226
  • [8] Effects of ticagrelor versus clopidogrel on platelet function in fibrinolytic-treated STEMI patients undergoing early PCI
    Dehghani, Payam
    Lavoie, Andrea
    Lavi, Shahar
    Crawford, Jennifer J.
    Harenberg, Sebastian
    Zimmermann, Rodney H.
    Booker, Jeff
    Kelly, Sheila
    Cantor, Warren J.
    Mehta, Shamir R.
    Bagai, Akshay
    Goodman, Shaun G.
    Cheema, Asim N.
    [J]. AMERICAN HEART JOURNAL, 2017, 192 : 105 - 112
  • [9] Effects of pretreatment with clopidogrel on platelet and coagulation activation in patients undergoing elective coronary stenting
    Weltermann, A
    Fritsch, P
    Kyrle, PA
    Schoenauer, V
    Heinze, G
    Wojta, J
    Christ, G
    Huber, K
    [J]. THROMBOSIS RESEARCH, 2003, 112 (1-2) : 19 - 24
  • [10] Clopidogrel Attenuates Coated-platelet Production in Patients Undergoing Elective Coronary Catheterization
    Norgard, Nicholas B.
    Saya, S.
    Hann, C. L.
    Hennebry, T. A.
    Schechtet, E.
    Dale, G. L.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2008, 52 (06) : 536 - 539